Reply to Wilson et al.: The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution

Jussi Saukkonen; Sonal Munsiff; Carla Winston; Raquel Duarte; Manoj Mammen

doi:10.1164/rccm.202503-0679LE

Reply to Wilson et al. The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution

Jussi Saukkonen
, Sonal Munsiff
, Carla Winston
, Raquel Duarte
, Manoj Mammen

Jacobs School of Medicine and Biomedical Sciences

Boston University
Division of Infectious Disease
Centers for Disease Control and Prevention
National Institute of Health Dr. Ricardo Jorge

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1526
Number of pages	1
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	211
Issue number	8
DOIs	https://doi.org/10.1164/rccm.202503-0679LE
State	Published - Aug 2025

Access to Document

10.1164/rccm.202503-0679LE

Cite this

@article{4b97d37d7f064d94afe512d03ffd98cb,

title = "Reply to Wilson et al.: The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution",

author = "Jussi Saukkonen and Sonal Munsiff and Carla Winston and Raquel Duarte and Manoj Mammen",

year = "2025",

month = aug,

doi = "10.1164/rccm.202503-0679LE",

language = "English",

volume = "211",

pages = "1526",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "Oxford University Press",

number = "8",

}

Reply to Wilson et al. The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution. / Saukkonen, Jussi; Munsiff, Sonal; Winston, Carla et al.
In: American Journal of Respiratory and Critical Care Medicine, Vol. 211, No. 8, 08.2025, p. 1526.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Reply to Wilson et al.

T2 - The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution

AU - Saukkonen, Jussi

AU - Munsiff, Sonal

AU - Winston, Carla

AU - Duarte, Raquel

AU - Mammen, Manoj

PY - 2025/8

Y1 - 2025/8

UR - https://www.scopus.com/pages/publications/105012756441

U2 - 10.1164/rccm.202503-0679LE

DO - 10.1164/rccm.202503-0679LE

M3 - Letter

C2 - 40505149

AN - SCOPUS:105012756441

SN - 1073-449X

VL - 211

SP - 1526

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

IS - 8

ER -

Reply to Wilson et al. The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution

Access to Document

Other files and links

Fingerprint

Cite this